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A validation of the diathesis-stress model
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Aleix Arnau-Soler 1, Mark J. Adams 2, Toni-Kim Clarke2, Donald J. MacIntyre 2, Keith Milburn3, Lauren Navrady 2,
Generation Scotland,Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium,
Caroline Hayward 4, Andrew McIntosh 2,5 and Pippa A. Thomson 1,5
Abstract
Depression has well-established influences from genetic and environmental risk factors. This has led to the diathesis-
stress theory, which assumes a multiplicative gene-by-environment interaction (GxE) effect on risk. Recently, Colodro-
Conde et al. empirically tested this theory, using the polygenic risk score for major depressive disorder (PRS, genes) and
stressful life events (SLE, environment) effects on depressive symptoms, identifying significant GxE effects with an
additive contribution to liability. We have tested the diathesis-stress theory on an independent sample of 4919
individuals. We identified nominally significant positive GxE effects in the full cohort (R2= 0.08%, p= 0.049) and in
women (R2= 0.19%, p= 0.017), but not in men (R2= 0.15%, p= 0.07). GxE effects were nominally significant, but only
in women, when SLE were split into those in which the respondent plays an active or passive role (R2= 0.15%, p=
0.038; R2= 0.16%, p= 0.033, respectively). High PRS increased the risk of depression in participants reporting high
numbers of SLE (p= 2.86 × 10−4). However, in those participants who reported no recent SLE, a higher PRS appeared
to increase the risk of depressive symptoms in men (β= 0.082, p= 0.016) but had a protective effect in women (β=
−0.061, p= 0.037). This difference was nominally significant (p= 0.017). Our study reinforces the evidence of
additional risk in the aetiology of depression due to GxE effects. However, larger sample sizes are required to robustly
validate these findings.
Introduction
Stressful life events (SLE) have been consistently
recognized as a determinant of depressive symptoms, with
many studies reporting significant associations between
SLE and major depressive disorder (MDD)1–7. Some
studies suggest that severe adversity is present before the
onset of illness in over 50% of individuals with depression8
and may characterize a subtype of cases9. However, some
individuals facing severe stress never present symptoms of
depression10. This has led to a suggestion that the
interaction between stress and an individual’s vulner-
ability, or diathesis, is a key element in the development of
depressive symptoms. Such vulnerability can be conceived
as a set of biological factors that predispose to illness.
Several diathesis-stress models have been successfully
applied across many psychopathologies11–15.
The diathesis-stress model proposes that a latent dia-
thesis may be activated by stress before psychopatholo-
gical symptoms manifest. Some levels of diathesis to
illness are present in everybody, with a threshold over
which symptoms will appear. Exceeding such a threshold
depends on the interaction between diathesis and the
degree of adversity faced in SLE, which increases the lia-
bility to depression beyond the combined additive effects
of the diathesis and stress alone11. Genetic risk factors
can, therefore, be conceived as a genetic diathesis. Thus,
this genetically driven effect produced by the diathesis-
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stress interaction can be seen as a gene-by-environment
interaction (GxE).
MDD is characterized by a highly polygenic archi-
tecture, composed of common variants with small effect
and/or rare variants16. Therefore, interactions in depres-
sion are also expected to be highly polygenic. In recent
years, with the increasing success of genome-wide asso-
ciation studies, GxE studies in depression have shifted
towards hypothesis-free genome-wide and polygenic
approaches that capture liability to depression using
genetic data17–23,24. Recent advances in genomics and the
massive effort from national institutions to collect genetic,
clinical and environmental data on large population-based
samples now provide an opportunity to empirically test
the diathesis-stress model for depression. The construc-
tion of polygenic risk scores (PRS) offers a novel paradigm
to quantify genetic diathesis into a single genetic measure,
allowing us to study GxE effects with more predictive
power than any single variant25–28. PRS are genetic indi-
cators of the aggregated number of risk alleles carried by
an individual weighted by their allelic effect estimated
from genome-wide association studies. This polygenic
approach to assessing the diathesis-stress model for
depression has been tested using either childhood
trauma17,19,24 or adult SLE18,23,24 as measures of envir-
onmental adversity.
Recently, Colodro-Conde et al.23 provided a direct test
of the diathesis-stressmodel for recent SLE and depressive
symptoms. In this study, Colodro-Conde et al. used PRS
weighted by the most recent genome-wide meta-analysis
conducted by the Psychiatric Genetics Consortium (PGC;
N= 159,601), and measures of three environmental
exposures: lack of social support, “personal” SLE, and
“network” SLE. Colodro-Conde et al. reported a sig-
nificant additive risk on liability to depression due to a
GxE effect in individuals who combine a high genetic
predisposition to MDD and a high number of reported
“personal” SLE, mainly driven by effects in women. A
significant effect of interaction was not detected in males.
They found no significant interaction between the genetic
diathesis and “network” SLE or social support. They
concluded that the effect of stress on risk of depression
was dependent on an individual’s diathesis, thus sup-
porting the diathesis-stress theory. In addition, they sug-
gested possible sex-specific differences in the aetiology of
depression. However, Colodro-Conde et al. findings have
not, to our knowledge, been independently validated.
In the present study, we aim to test the diathesis-stress
model in an independent sample of 4919 unrelated white
British participants from a further longitudinal follow-up
from Generation Scotland, and assess the differences
between women and men, using self-reported depressive
symptoms and recent SLE.
Materials and methods
Sample description
Generation Scotland is a family-based population
cohort recruited throughout Scotland by a cross-
disciplinary collaboration of Scottish medical schools
and the National Health Service (NHS) between 2006 and
201129. At baseline, blood and salivary DNA samples from
Generation Scotland participants were collected, stored
and genotyped at the Wellcome Trust Clinical Research
Facility, Edinburgh. Genome-wide genotype data were
generated using the Illumina
HumanOmniExpressExome-8 v1.0 DNA Analysis Bead-
Chip (San Diego, CA, USA) and Infinium chemistry30.
The procedures and further details for DNA extraction
and genotyping have been extensively described else-
where31,32. In 2014, 21,525 participants from Generation
Scotland eligible for re-contact were sent self-reported
questionnaires as part of a further longitudinal assessment
funded by a Wellcome Trust Strategic Award “STratifying
Resilience and Depression Longitudinally” (STRADL)33 to
collect new and updated mental health questionnaires
including psychiatric symptoms and SLE measures. 9618
re-contacted participants from Generation Scotland
agreed to provide new measures to the mental health
follow-up33 (44.7% response rate). Duplicate samples,
those showing sex discrepancies with phenotypic data, or
that had more than 2% missing genotype data, were
removed from the sample, as were samples identified as
population outliers in principal component analysis
(mainly non-Caucasians and Italian ancestry subgroups).
In addition, individuals with diagnoses of bipolar disorder,
or with missing SLE data, were excluded from the ana-
lyses. SNPs with more than 2% of genotypes missing,
Hardy-Weinberg Equilibrium test p < 1 × 10−6, or a minor
allele frequency lower than 1%, were excluded. Individuals
were then filtered by degree of relatedness (pi-hat < 0.05)
using PLINK v1.934, maximizing retention of those par-
ticipants reporting higher numbers of SLE (see phenotype
assessment below). After quality control, the final dataset
comprised 4919 unrelated individuals of European
ancestry and 560 351 SNPs (mean age at questionnaire:
57.2, s.d.= 12.2, range 22–95; women: n= 2990–60.8%,
mean age 56.1, s.d.= 12.4; men: n= 1 929–39.2%, mean
age 58.7, s.d.= 11.8). Further details on the recruitment
procedure and Generation Scotland profile are described
in detail elsewhere29,31,35–37. All participants provided
written consent. All components of Generation Scotland
and STRADL obtained ethical approval from the Tayside
Committee on Medical Research Ethics on behalf of the
National Health Service (reference 05/s1401/89). Gen-
eration Scotland data is available to researchers on
application to the Generation Scotland Access Committee
(access@generationscotland.org).
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Phenotype assessment
Participant self-reported current depressive symptoms
through the 28-item scaled version of The General Health
Questionnaire38,39. The General Health Questionnaire is a
reliable and validated psychometric screening tool to
detect common psychiatric and non-psychotic conditions
(General Health Questionnaire Cronbach alpha coeffi-
cient: 0.82–0.86)40. This consists of 28 items designed to
identify whether an individual’s current mental state has
changed over the last 2 weeks from their typical state. The
questionnaire captures core symptoms of depression
through subscales for severe depression, emotional (e.g.,
anxiety and social dysfunction) and somatic symptoms
linked to depression. These subscales are highly corre-
lated41 and suggest an overall general factor of depres-
sion42. Participants rated the 28 items on a four-point
Likert scale from 0 to 3 to assess its degree or severity40
(e.g., Have you recently felt that life is entirely hopeless?
“Not at all”, “No more than usual”, “Rather more than
usual”, “Much more than usual”), resulting on an 84-point
scale depression score. The Likert scale, which provides a
wider and smoother distribution40, may be more sensitive
to detect changes in mental status in those participants
with chronic conditions or chronic stress who may feel
their current symptoms as “usual”43, and to detect psy-
chopathology changes as response to stress. The final
depression score was log transformed to reduce the effect
of positive skew and provide a better approximation to a
normal distribution. In addition, participants completed
the Composite International Diagnostic Interview–Short
Form, which diagnoses lifetime history of MDD according
to DSM-IV criteria44. The depression score predicted
lifetime history of MDD (odd ratio= 1.91, 95% confidence
intervals 1.80–2.02, p= 1.55 × 10−102, N= 8994), with a
3.8-fold increased odds of having a lifetime history of
MDD between participants in the top and bottom deciles,
thus supporting the usefulness of the depression score in
understanding MDD. To improve interpretation, we
scaled the depression score to a mean of 0 when required
(Fig. 3).
Data from a self-reported questionnaire based on the
List of Threating Experiences45 was used to construct a
measure of common SLE over the previous 6 months. The
List of Threatening Experiences is a reliable psychometric
device to measure psychological “stress”46,47. It consists of
a 12-item questionnaire to assess SLE with considerable
long-term contextual effects (e.g., Over last 6 months, did
you have a serious problem with a close friend, neighbor or
relatives?). A final score reflecting the total number of SLE
(TSLE) ranging from 0 to 12 was constructed by summing
the “yes” responses. Additionally, TSLE was split into two
categories based on those items measuring SLE in which
the individual may play and active role exposure to SLE,
and therefore in which the SLE is influenced by genetic
factors and thus subject to be “dependent” on an indivi-
dual’s own behavior or symptoms (DSLE; 6 items, e.g., a
serious problem with a close friend, neighbor or relatives
may be subject to a respondent’s own behavior), or SLE
that are not influenced by genetic factors, likely to be
“independent” on a participant’s own behavior (ISLE; 5
items, e.g., a serious illness, injury or assault happening to
a close relative is potentially independent of a respon-
dent’s own behavior)45,48. The item “Did you/your wife or
partner give birth?” was excluded from this categorization.
In addition, SLE reported were categorized to investigate
the diathesis effect at different levels of exposure,
including a group to test the diathesis effect when SLE is
not reported. Three levels of SLE reported were defined (0
SLE= “none”, 1 or 2 SLE= “low”, and 3 or more SLE
= “high”) to retain a large enough sample size for each
group to allow meaningful statistical comparison.
Polygenic profiling and statistical analysis
Polygenic risk scores (PRS) were generated by PRSice49,
whose functionality relies mostly on PLINK v1.934, and
were calculated using the genotype data of Generation
Scotland participants (i.e., target sample) and summary
statistics for MDD from the PGC-MDD2 GWAS release
(July 2016, discovery sample) used by Colodro-Conde
et al.23, with the added contribution from QIMR cohort
and the exclusion of Generation Scotland participants,
resulting in summary statistics for MDD derived from a
sample of 50,455 cases and 105,411 controls.
Briefly, PRSice removed strand-ambiguous SNPs and
clump-based pruned (r2= 0.1, within a 10Mb window)
our target sample to obtain the most significant inde-
pendent SNPs in approximate linkage equilibrium. Inde-
pendent risk alleles were then weighted by the allelic
effect sizes estimated in the independent discovery sample
and aggregated into PRS. PRS were generated for eight p
thresholds (p thresholds: < 5 × 10−8, < 1 × 10−5, < 0.001, <
0.01, < 0.05, < 0.1, < 0.5, <= 1) determined by the dis-
covery sample and standardized (See Supplementary
Table 1 for summary of PRS).
A genetic relationship matrix (GRM) was calculated for
each dataset (i.e., full cohort, women, and men) using
GCTA 1.26.050. Mixed linear models using the GRM were
used to estimate the variance in depression score
explained by PRS, SLEs and their interaction; and strati-
fied by sex. Twenty principal components were calculated
for the datasets.
The mixed linear model used to assess the effects of PRS
is as follows:
Depression ¼ β0 þ β1PRS þ GRM þ Covariates
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Mixed linear models used to assess the effect of the
stressors are as follows:
Depression ¼ β0 þ β1TSLE þ GRM þ Covariates
Depression ¼ β0 þ β1DSLE þ GRM þ Covariates
Depression ¼ β0 þ β1ISLE þ GRM þ Covariates
Following Colodro-Conde et al.23, covariates (i.e., age,
age2, sex, age-by-sex and age2-by-sex interactions, and 20
principal components) were regressed from PRS (PRS’)
and SLE scores (i.e., TSLE’, DSLE’ and ISLE’; SLEs’) before
fitting models in GCTA to guard against confounding
influences on the PRS-by-SLEs interactions51. PRS’ and
SLEs’ were standardized to a mean of 0 and a standard
deviation of 1. The Mixed linear models (i.e., the
diathesis-stress model) used to assess GxE effects are as
follows:
Depression ¼ β0 þ β1PRS′ þ β2TSLE′
þ β3PRS′xTSLE′ þ GRM þ Covariates
Depression ¼ β0 þ β1PRS′ þ β2DSLE′
þ β3PRS′xDSLE′ þ GRM þ Covariates
Depression ¼ β0 þ β1PRS′ þ β2ISLE′ þ β3PRS′xISLE′
þGRM þ Covariates
Covariates fitted in the models above were age, age2,
sex, age-by-sex, age2-by-sex, and 20 principal compo-
nents. Sex and its interactions (age-by-sex and age2-by-
sex) were omitted from the covariates when stratifying by
sex. All parameters from the models were estimated using
GCTA and the significance of the effect (β) from fixed
effects assessed using a Wald test. The significance of
main effects (PRS and SLEs) allowed for nominally testing
the significance of interactions at p-threshold= 0.05. To
account for multiple testing correction, a Bonferroni’s
adjustment correcting for 8 PRS and 3 measures of SLE
tested (24 tests) was used to establish a robust threshold
for significance at p= 2.08 × 10−3.
The PRS effect on depression score at different levels of
exposure was further examined for the detected nominally
significant interactions by categorizing participants on
three groups based on the number of SLE reported (i.e.,
“none”, “low” or “high”). Using linear regression, we
applied a least squares approach to assess PRS’ effects on
the depression score in each SLE category. Further con-
servative Bonferroni correction to adjust for the 3 SLE
categories tested established a threshold for significance
of p= 6.94 × 10−4.
Differences on the estimated size of GxE effect between
women and men were assessed by comparing a z-score to
the standard normal distribution (α= 0.05, one-tailed). Z-
scores were derived from GxE estimates (β) and standard
errors (SE) detected in women and men as follows:





PRS for MDD significantly predicted the depression
score across the whole sample (β= 0.080, s.e.= 0.014,
p= 7.53 × 10−9) explaining 0.64% of the variance at its
best p-threshold (p-threshold= 0.1; Fig. 1a). Stratifying
by sex, PRS significantly predicted the depression score
in both sexes, explaining 0.59% in men and 0.67% in
women (men: p-threshold= 0.1, β= 0.077, s.e.= 0.022,
p= 2.09 × 10−4; women: p-threshold= 0.1, β= 0.082, s.
e.= 0.018, p= 4.93 × 10−6; Fig. 1a). Self-reported SLE
over the last 6 months (TSLE, mean= 1.3 SLE, s.d.=
1.5) also significantly predicted depression score for the
whole sample and stratified by sex (full cohort: variance
explained= 4.91%, β= 0.222, s.e.= 0.014, p= 9.98 ×
10−59; men: 4.19%, β= 0.205, s.e.= 0.021, p= 2.23 ×
10−22; women: 5.33%, β= 0.231, s.e.= 0.018, p= 7.48 ×
10−38; Fig. 1b). Overall, significant additive contribu-
tions from genetics and SLE to depression score were
detected in all participants and across sexes. There was
no significant difference in the direct effect of TSLE
between women and men (p= 0.17). However, the
variance in depression score explained by the TSLE
appeared to be lower than the variance explained by the
measure of personal SLE (PSLE) used in Colodro-
Conde et al.23 (12.9%). This may, in part, be explained
by different contributions of dependent and indepen-
dent SLE items screened in Colodro-Conde et al.
compared to our study. Although questions about
dependent SLE (DSLE, mean= 0.4 SLE) represented
over 28% of the TSLE-items reported in our study, the
main effect of DSLE explained approximately 93% of the
amount of variance explained by TSLE (full cohort:
variance explained= 4.56%, β= 0.212, s.e.= 0.014, p=
1.73 × 10−54; men: 3.74%, β= 0.193, s.e.= 0.021, p=
9.66 × 10−21; women: 5.07%, β= 0.225, s.e.= 0.018, p=
8.09 × 10−35; Fig. 1b). Independent SLE (ISLE, mean=
0.85 SLE), which represented over 69% of TSLE-items,
explained approximately 57% of the amount of variance
explained by TSLE (full cohort: variance explained=
2.80%, β= 0.167, s.e.= 0.014, p= 1.32 × 10−33; men:
2.44%, β= 0.156, s.e.= 0.022, p= 2.88 × 10−13; women:
3.02%, β= 0.174, s.e.= 0.018, p= 5.20 × 10−22; Fig. 1b).
To explore the contribution from each measure, we
combined DSLE and ISLE together in a single model.
DSLE explained 3.34% of the variance in depression
score compared to 1.45% of the variance being
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explained by ISLE, suggesting that DSLE have a greater
effect on liability to depressive symptoms than ISLE.
A diathesis-stress model for depression was tested to
assess GxE effects. We detected significant, albeit weak,
GxE effects on depression score (Fig. 2). The PRS inter-
action with TSLE was nominally significant in the full
cohort (β= 0.028, s.e.= 0.014, R2= 0.08%, p= 0.049) and
slightly stronger in women (β= 0.044, s.e.= 0.018, R2=
0.19%, p= 0.017; Fig. 2a), compared to men in which the
effect was not significant (β= 0.039, s.e.= 0.022, R2=
0.15%, p= 0.07). However, these results did not survive
correction for multiple testing (p > 2.08 × 10-3).
The best-fit threshold was much lower in women (p-
threshold= 1 × 10−5) compared to the full sample (p-
threshold= 0.01). The size of the GxE effects across sexes
at p-threshold= 1 × 10−5 were significantly different
(GxE*sex p= 0.017), but not at the best p-threshold in the
full cohort (p-threshold= 0.01, GxE*sex p= 0.32; Fig. 2a).
In women, GxE effect with DSLE predicted depression
score (p-threshold= 1 × 10−5; β= 0.039, s.e.= 0.019, R2
= 0.15%, p= 0.038; Fig. 2b and Supplementary Fig. 2a), as
did the GxE effect with ISLE (p-threshold= 1 × 10−5; β=
0.040, s.e.= 0.019, R2= 0.16%, p= 0.033; Fig. 2c and
Supplementary Fig. 2b). No significant interaction was
detected in men (best-fit p-threshold= 0.1) with either
TSLE (β= 0.039, s.e.= 0.022, R2= 0.15%, p= 0.072; Fig.
2a), DSLE (β= 0.024, s.e.= 0.022, R2= 0.06%, p= 0.28;
Fig. 2b) or ISLE (β= 0.043, s.e.= 0.022, R2= 0.18%, p=
0.055; Fig. 2c).
To examine these results further and investigate the
diathesis effect at different levels of stress, nominally
significant GxE were plotted between PRS and categories
of SLE (i.e, “none”, “low”, and “high” SLE reported; Fig. 3).
Examining the interaction found in the full cohort (PRS at
PGC-MDD GWAS p-threshold= 0.01), we detected a
significant direct diathesis effect on the risk of depressive
symptoms in those participants reporting SLE, with a
higher risk when greater numbers of SLE were reported
(“low” number of SLE reported: PRS’ β= 0.043, s.e.=
0.021, p= 0.039; “high” number of SLE reported: PRS’ β
= 0.142, s.e.= 0.039, p= 2.86 × 10−4; see Table 1 and Fig.
3a). Whereas, in participants who reported no SLE over
the preceding 6 months, the risk of depressive symptoms
was the same regardless of their diathesis risk (“none” SLE
reported: PRS’ β= 0.021, s.e.= 0.022, p= 0.339). Strati-
fying these results by sex, we found the same pattern as in
the full cohort in women (“none”: p= 0.687; “low”: p=
0.023; “high”: p= 2 × 10-3), but not in men (“none”: p=
0.307; “low”: p= 728; “high”: p= 0.053; see Table 1 and
Fig. 3a). However, the lack of a significant diathesis effect
in men may be due to their lower sample size and its
corresponding reduced power.
Examining the interaction with PRS at PGC-MDD
GWAS p-threshold= 1 × 10−5, with which a significant
Fig. 1 Prediction of depression symptoms and SLE using the PRS
for MDD. a Association between polygenic risk scores (PRS) and
depression score (main effects, one-sided tests). PRS were generated
at 8 p-threshold levels using summary statistics from the Psychiatric
Genetic Consortium MDD GWAS (released July 2016) with the
exclusion of Generation Scotland participants. The depression score
was derived from The General Health Questionnaire. The Y-axis
represents the % of variance of depression score explained by PRS
main effects. The full cohort (yellow) was split into men (blue) and
women (red). In Colodro-Conde et al. PRS for MDD significantly
explained up to 0.46% of depression score in their sample (~0.39% in
women and ~0.70% in men). b Association between reported number
of SLE and depression score (main effect, one-sided tests, results
expressed in % of variance in depression score explained). SLE were
self-reported through a brief life-events questionnaire based on the
List of Threatening Experiences and categorized into: total number of
SLE reported (TSLE), “dependent” SLE (DSLE) or “independent” SLE
(ISLE). The full cohort (yellow) was split into men (blue) and women
(red). In Colodro-Conde et al. “personal” SLE significantly explained up
to 12.9% of depression score variance in their sample (~11.5% in
women and ~16% in men)23
Arnau-Soler et al. Translational Psychiatry            (2019) 9:25 Page 5 of 10
interaction was detected in women, we detected a sig-
nificant diathesis effect on depression score only when
stratifying by sex in those participants who did not
reported SLE over the last 6 months (see Table 1). The
diathesis effect was positive in men (PRS’ β= 0.082, s.e.=
0.034, p= 0.016, R2= 0.7%; Fig. 3b), consistent with the
contribution of risk alleles. Conversely, the diathesis effect
was negative in women (PRS’ β= -0.061, s.e.= 0.029, p=
0.037, R2= 0.4%; Fig. 3b), suggesting a protective effect of
increasing PRS in those women reporting no SLE, and
consistent with the contribution of alleles to individual
sensitivity to both positive and negative environmental
effects (i.e., “plasticity alleles” rather than “risk
alleles”)52,53. This PRS accounted for the effect of just 34
SNPs, and the size of its GxE across sexes were sig-
nificantly different (GxE*sex p= 0.017; Fig. 2a), support-
ing possible differences in the underlying stress-response
mechanisms between women and men.
Discussion
The findings reported in this study support those from
Colodro-Conde et al.23, in an independent sample of
similar sample size and study design, and also supports
possible sex-specific differences in the effect of genetic
risk of MDD in response to SLE.
Both Colodro-Conde et al. and our study suggest that
individuals with an inherent genetic predisposition to
MDD, reporting high number of recent SLE, are at
additional risk of depressive symptoms due to GxE effects,
thus validating the diathesis-stress theory. We identified
nominally significant GxE effects in liability to depression
at the population level (p= 0.049) and in women (p=
0.017), but not in men (p= 0.072). However, these
interactions did not survive multiple testing correction (p
> 2.08 × 10−3) and the power of both studies to draw
robust conclusions remains limited54. With increased
power these studies could determine more accurately
both the presence and magnitude of a GxE effect in
depression. To better understand the effect of PRS at
different levels of exposure to stress, we examined the
nominally significant interactions detected in the full
sample by categorizing participants on three groups based
on the number of SLE reported (i.e., “none”, “low” or
“high”). We detected a significant diathesis effect on risk
of depression only in those participants reporting SLE, but
not in those participants that reported no SLE over the
preceding 6 months. Furthermore, the diathesis effect was
stronger on those participants reporting a “high” number
of SLE (β= 0.142, p= 2.86 × 10−4) compared to those
participants reporting a “low” number of SLE (β= 0.043,
p= 0.039). The former effect was significant and survived
a conservative Bonferroni correction to adjust for multiple
testing (p < 6.94 × 10−4). This finding corroborates the
diathesis-stress model for depression and supports the
results of Colodro-Conde et al. in an independent sample.
To investigate the relative contribution of the GxE to the
variance of depression, we examined in the full cohort the
total variance of depression score explained by the PRS
main effect and the significant GxE effect jointly. Together,
they explained 0.34% of the variance, of which 0.07% of the
variance of the depression score was attributed to the GxE
effect (p-threshold= 0.01; PRS p= 1.19 × 10−4, GxE p=
Fig. 2 Association between GxE effect and depression score. The plots show the percentage of depression score explained by the interaction
term (two-sided tests) fitted in linear mixed models to empirically test the diathesis-stress model. Red numbers show significant interactions p-values.
*Shows the significance of the difference in variance explained between sexes. The full cohort (yellow) was split into men (blue) and women (red).
PRS were generated at 8 p-threshold levels using summary statistics from the Psychiatric Genetic Consortium MDD GWAS (released July 2016) with
the exclusion of Generation Scotland participants. The interaction effect was tested with the number of: (a) SLE (TSLE), (b) “dependent” SLE (DSLE)
and c) “independent” SLE (ISLE). In Colodro-Conde et al., the variance of depression score explained in their sample by GxE was 0.12% (p= 7 × 10−3).
GxE were also significant in women (p= 2 × 10-3) explaining up to 0.25% of depression score variation, but not in men (p= 0.059; R2= 0.17%;
negative/protective effect on depression score)
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0.049; both derived from the full diathesis-model with
TSLE). This is lower than the proportion of variance
attributed to common SNPs (8.9%) in the full PGC-MDD
analysis16. As Colodro-Conde et al. noted, this result aligns
with estimates from experimental organisms suggesting
that around 20% of the heritability may be typically attrib-
uted to the effects of GxE55, although it is inconsistent with
twin studies of the majority of human traits with the
potential exception of depression56.
Consistent with PRS predicting “personal” SLE in
Colodro-Conde et al., PRS for MDD predicted SLE in our
study (see Supplementary Fig. 1), although not at the p-
threshold at which significant GxE effects were detected.
Genetic factors predisposing to MDD may contribute to
individuals exposing themselves to, or showing an
increased reporting of, SLE via behavioral or personality
traits57,58. Such genetic mediation of the association
between depression and SLE would disclose a gene-
environment correlation (i.e., genetic effects on the
probability of undergoing a SLE) that hinders interpretion
of our findings as pure GxE effects59,60. To address this
limitation and assess this aspect, following Colodro-
Conde et al., we split the 12-items TSLE measure into
SLE that are either potentially “dependent” of a partici-
pant’s own behavior (DSLE; therefore, potentially driven
by genetic factors) or not (“independent” SLE; ISLE)45,48.
DSLE are reported to be more heritable and have stronger
associations with MDD than ISLE48,61,57. In our sample,
DSLE is significantly heritable (h2SNP=0.131, s.e.= 0.071,
p= 0.029), supporting a genetic mediation of the asso-
ciation, whereas ISLE is not significantly heritable (h2SNP
= 0.000, s.e.= 0.072, p= 0.5)
62. Nominally significant GxE
effects were seen in women for both DSLE and ISLE,
suggesting that both GxE and gene-environment corre-
lation co-occur. Colodro-Conde et al. did not identify
significant GxE using independent SLE as the exposure.
Fig. 3 Scatterplot of diathesis-stress interactions on depression score. Interactions with PRS at which nominally significant GxE effects were
detected in (a) full cohort (p-threshold= 0.01) and (b) in women (p-threshold= 1 × 10–5) are shown. At bottom, the remaining samples (i.e., full
cohort, women or men) at same p-threshold are shown for comparison. The X-axis represents the direct effect of PRS (standard deviation from the
mean) based on (a) p-threshold= 0.01 and (b) p-threshold= 1 × 10–5, using the total number of SLE reported by each participant (dot) as
environmental exposures at three SLE levels represented by colors. Blue: 0 SLE, “no stress”, n= 1 833/1 041/792; green: 1 or 2 SLE, “low stress”, n= 2
311/1 459/852; red: 3 or more SLE, “high stress”, n= 775/490/285; in the full cohort, women and men, respectively. Y-axis reflects the depression score
standardized to mean of 0 and standard deviation of 1. Lines represent the increment in risk of depression at a certain degree of “stress” dependent
on a genetic predisposition (= diathesis)
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Between-sex differences in stress response could help to
explain previous differences seen between sexes in
depression such as those in associated risk (i.e., approxi-
mately 1.5–2-fold higher in women), symptoms reported
and/or coping strategies (e.g., whereas women tend to
cope through verbal and emotional strategies, men tend
to cope by doing sport and consuming alcohol)63–67. This
also aligns with an increased risk associated with a lack of
social support seen in women compared to men23. Fur-
thermore, although we do not know whether participants
experienced recent events with positive effects, we saw a
protective effect in those women who did not experienced
recent SLE (p= 0.037), suggesting that some genetic
variants associated with MDD may operate as “plasticity
alleles” and not just as “risk alleles”52,53. This effect was
neutralized in the full cohort due to an opposite effect in
men (p= 0.016), but it is supported by previous protective
effects reported when using a serotoninergic multilocus
profile score and absence of SLE in young women68.
These findings would be consistent with a differential-
susceptibility model of depression69,70, also suggested by
the interaction effects seen between the serotonin trans-
porter linked promoter region gene (5-HTTLPR) locus
and family support and liability to adolescent depression
in boys71. However, our results and the examples given
are only nominally significant and will require replication
in larger samples. Robust identification of sex-specific
differences in genetic stress-response could improve
personalized treatments and therapies such as better
coping strategies.
There are notable differences between our study and
Colodro-Conde et al. to consider before accepting our
findings as a replication of their results. First, differences in
PRS profiling may have affected replication power. We used
the same equivalent PGC-MDD2 GWAS as discovery
sample. However, whereas Colodro-Conde et al. generated
PRS in their target sample containing over 9.5M imputed
SNP, in this study we generated PRS in a target sample of
over 560 K genotyped SNPs (see Supplementary table 1 for
comparison). This potentially results in a less informative
PRS in our study, with less predictive power, although the
variance explained by our PRS was slightly larger (0.64% vs.
0.46%). The size of the discovery sample is key to con-
structing an accurate predictive PRS, but to exploit the
greatest number of the available variants may be an asset54.
Secondly, different screening tools were used to measure
both current depressive symptoms and recent environ-
mental stressors across the two studies. Both studies
transformed their data, using item response theory or by
log-transformation, to improve the data distribution.
Table 1 Diathesis effect on depression score in three SLE categories
Sample Full cohorta Women Men
SLE category None Low High None Low High None Low High
PRS at p value threshold= 0.01
N 1833 2311 775 1041 1459 490 792 852 285
Effect 0.021 0.043 0.142 0.0118 0.0617 0.1538 0.0346 0.0113 0.1227
s.e. 0.022 0.021 0.039 0.029 0.027 0.049 0.034 0.032 0.063
t 0.957 2.07 3.644 0.403 2.274 3.112 1.021 0.348 1.947
p value 0.339 0.039 2.86 × 10-4 0.687 0.023 0.002 0.307 0.728 0.053
CI (95%) −0.022, 0.065 0.002, 0.084 0.065, 0.218 −0.046, 0.069 0.008, 0.115 0.057, 0.251 −0.032, 0.101 −0.052, 0.075 −0.001,0.247
Sample Full cohort Womena Men
SLE category None Low High None Low High None Low High
PRS at p value threshold= 1 × 10−5
N 1833 2311 775 1041 1459 490 792 852 285
Effect −0.0022 0.0032 0.0705 −0.061 0.014 0.078 0.082 −0.0176 0.0548
s.e. 0.022 0.021 0.04 0.029 0.027 0.049 0.034 0.033 0.07
t –0.098 0.153 1.76 −2.086 0.541 1.609 2.416 −0.537 0.778
p value 0.922 0.878 0.079 0.037 0.589 0.108 0.016 0.592 0.437
CI (95%) −0.046, 0.041 −0.037, 0.044 −0.008, 0.149 −0.119,
−0.004
−0.038, 0.066 −0.017, 0.174 0.015,
0.149
−0.082,0.047 −0.084, 0.193
Note: Reported values at p-thresholds where nominally significant GxE effects were detected
aSample where nominally significant GxE was detected. SLE categories (number of SLE reported): 0 SLE= “none”, 1 or 2 SLE= “low”, and 3 or more SLE= “high”. In
italic, nominally significant effects. In bold, robustly significant effect after conservative Bonferroni correction (p < 6.94 × 10−4)
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However, neither study used depression scores that were
normally distributed. The scale of the instruments used and
their corresponding parameterization when testing for an
interaction could have a direct effect on the size and sig-
nificance of their interaction;55,72 so findings from GxE
must be taken with caution. Furthermore, although both
screening methods have been validated and applied to
detect depressive symptoms, different questions may cover
and emphasize different features of the illness, which may
result in different results. The same applies to the mea-
surement of environmental stressors in the two studies.
Both covering of a longer time-period and upweighting by
“dependent” SLE items may explain the increased expla-
natory power of “personal” SLE (12.9%) in Colodro-Conde
et al. to predict depression score compared to our “total”
SLE measure (4.91%). Finally, the unmeasured aspects of
the exposure to SLE or its impact may also contribute to the
lack of a stronger replication and positive findings.
In conclusion, despite differences in the measures used
across studies, we saw concordance and similar patterns
between our results and those of Colodro-Conde et al.23
Our findings, therefore, add validity to the diathesis-stress
theory for depression. Empirically demonstrating the
diathesis-stress theory for depression would validate
recent20–22 and future studies using a genome-wide
approach to identify genetic mechanisms and interactive
pathways involved in GxE underpinning the causative
effect of “stress” in the development of depressive symp-
toms and in mental illness in general. This study adds to
our understanding of gene-by-environment interactions,
although larger samples will be required to confirm dif-
ferences in diathesis-stress effects between women and
men.
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